New research from Seed Grant recipient, Marina Pasca di Magliano, PhD, from the University of Michigan has deepened our understanding of the biology of pancreatic cancer, crucial to the development […]
New study establishes that ATM activity poses a major barrier to the development of cancer in the pancreas by maintaining genomic stability.
A new study published by our 2014-15 Seed Grant recipient, Yiannis Drosos, PhD has uncovered information that can help diagnose and treat pancreatic cancer tumors.
New two-pronged approach targets pancreatic stellate cells to prevent pancreatic cancer tumor growth
New research conducted at the Ingham Institute for Applied Medical Research in Liverpool, New South Wales, has found a new approach to treating pancreatic cancer. The research, published in Oncotarget, […]
Targeting an enzyme may provide metabolic treatment for pancreatic cancer
A new study released by our 2016-17 Seed Grant Awardee, Nada Kalaany, PhD shows evidence that targeting an enzyme that tumors use to get rid of nitrogen can slow tumor growth. These innovative therapeutic strategies are precisely why our Seed Grant Program is crucial in the fight against pancreatic cancer.
Chemotherapy nanoparticles offer breakthrough in pancreatic cancer drug delivery
Originally published at http://www.cancer.ucla.edu UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer Study shows the peptide enhances a […]
Study Explains Genetic Connection Between Aging and Cancer
David Gius, MD, PhD from Northwestern University was funded in the 2012 cycle of the Hirshberg Foundation’s annual Seed Grant Program. The results of the study explain the genetic connection […]